Latest News - Bonti

Thursday, August 02, 2018 | Personnel/Company News,, Research and Publications, Bonti

Bonti’s Novel Neurotoxin Shows Promise in Early Study of Scar Reduction After Mohs Surgery

Topline results from Bonti’s SHINE-1 Phase 2a clinical trial suggest that its novel neurotoxin is safe and likely effective for scar reduction following Mohs surgery. EB-001, the active ingre…

Read the full story

Monday, February 12, 2018 | Personnel/Company News,, Bonti

Jacob Chacko, MD Joins Bonti’s Board of Directors

Jacob Chacko, MD has joined Bonti’s Board of Directors. Dr. Chacko has served as the Chief Financial Officer of Ignyta, Inc. since May 2014. At Ignyta, he leads multiple functions, …

Read the full story